{"t": "Chapter 8E. Evaluation of Pharmaceutical Regulation.", "p": "/dc/council/code/titles/48/chapters/8E/", "et": "container", "dj": "/dc/council/code/index.json", "sc": "Chapter 8E of Title 48", "c": [{"t": "\u00a7 48\u2013844.01. Short title.", "p": "/dc/council/code/sections/48-844.01.html", "et": "section", "sc": "\u00a7 48-844.01"}, {"t": "\u00a7 48\u2013844.02. Definitions.", "p": "/dc/council/code/sections/48-844.02.html", "et": "section", "sc": "\u00a7 48-844.02", "c": [{"t": "(1)", "p": "/dc/council/code/sections/48-844.02.html#(1)", "et": "para", "sc": "\u00a7 48-844.02(1)", "x": "\u201cPharmaceutical product\u201d shall have the same meaning as provided in \u00a7 3-120"}, {"t": "(2)", "p": "/dc/council/code/sections/48-844.02.html#(2)", "et": "para", "sc": "\u00a7 48-844.02(2)", "x": "\u201cPractice of pharmaceutical detailing\u201d shall have the same meaning as provi"}]}, {"t": "\u00a7 48\u2013844.03. Evaluation.", "p": "/dc/council/code/sections/48-844.03.html", "et": "section", "sc": "\u00a7 48-844.03", "c": [{"t": "(a)", "p": "/dc/council/code/sections/48-844.03.html#(a)", "et": "para", "sc": "\u00a7 48-844.03(a)", "c": [{"t": "(1)", "p": "/dc/council/code/sections/48-844.03.html#(a)(1)", "et": "para", "sc": "\u00a7 48-844.03(a)(1)", "x": "The number of individuals licensed to engage in the practice of pharmaceuti"}, {"t": "(2)", "p": "/dc/council/code/sections/48-844.03.html#(a)(2)", "et": "para", "sc": "\u00a7 48-844.03(a)(2)", "x": "The number of applicants for licensure to engage in the practice of pharmac"}, {"t": "(3)", "p": "/dc/council/code/sections/48-844.03.html#(a)(3)", "et": "para", "sc": "\u00a7 48-844.03(a)(3)", "x": "The number of applicants for licensure to engage in the practice of pharmac"}, {"t": "(4)", "p": "/dc/council/code/sections/48-844.03.html#(a)(4)", "et": "para", "sc": "\u00a7 48-844.03(a)(4)", "x": "An assessment of the appropriateness and efficacy of the continuing educati"}, {"t": "(5)", "p": "/dc/council/code/sections/48-844.03.html#(a)(5)", "et": "para", "sc": "\u00a7 48-844.03(a)(5)", "x": "The number of individuals identified as engaging in the practice of pharmac"}, {"t": "(6)", "p": "/dc/council/code/sections/48-844.03.html#(a)(6)", "et": "para", "sc": "\u00a7 48-844.03(a)(6)", "x": "The amount of fines levied against persons charged with engaging in the pra"}, {"t": "(7)", "p": "/dc/council/code/sections/48-844.03.html#(a)(7)", "et": "para", "sc": "\u00a7 48-844.03(a)(7)", "x": "The total amount and origin of revenue deposited into the Board of Pharmacy"}, {"t": "(8)", "p": "/dc/council/code/sections/48-844.03.html#(a)(8)", "et": "para", "sc": "\u00a7 48-844.03(a)(8)", "x": "The total amount of funds deposited into the Board of Pharmacy Fund that we"}, {"t": "(9)", "p": "/dc/council/code/sections/48-844.03.html#(a)(9)", "et": "para", "sc": "\u00a7 48-844.03(a)(9)", "x": "The number and types of penalties levied for failure to comply with the req"}, {"t": "(10)", "p": "/dc/council/code/sections/48-844.03.html#(a)(10)", "et": "para", "sc": "\u00a7 48-844.03(a)(10)", "x": "The number and amount of fines levied for violations as a result of pharmac"}, {"t": "(11)", "p": "/dc/council/code/sections/48-844.03.html#(a)(11)", "et": "para", "sc": "\u00a7 48-844.03(a)(11)", "x": "The number of persons who participated in the Pharmaceutical Education Prog"}, {"t": "(12)", "p": "/dc/council/code/sections/48-844.03.html#(a)(12)", "et": "para", "sc": "\u00a7 48-844.03(a)(12)", "x": "An assessment of the quality and effectiveness of the Pharmaceutical Educat"}, {"t": "(13)", "p": "/dc/council/code/sections/48-844.03.html#(a)(13)", "et": "para", "sc": "\u00a7 48-844.03(a)(13)", "x": "An assessment of the extent to which regulation of the practice of pharmace"}], "x": "Within 60 days of September 30, 2010, the Department of Health shall submit"}, {"t": "(b)", "p": "/dc/council/code/sections/48-844.03.html#(b)", "et": "para", "sc": "\u00a7 48-844.03(b)", "x": "The evaluation may be used to determine if D.C. Law 17-131 should be repeal"}]}]}